Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

943172

	registered interest
	date	17/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Pharmacy: Digital Technology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to prepare the pharmacy sector for (a) digital first pharmacy services and (b) other technological change.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	165012
	answer	answer is ministerial correction date of answer 23/07/2018 answer text <p>The community pharmacy IT infrastructure is being modernised, enabling the integration of community pharmacies within the wider National Health Service. In 2016 the Quality Payments Scheme was introduced to align an element of payment to quality and to support integration. The scheme has led to a number of improvements including the roll out of NHS Mail to 11,411 pharmacies across England, enabling digital communication of patient information. Continued integration will support the delivery of digital services in future.</p><p> </p><p>We have also made good progress to enhance the tools pharmacy professionals have at their disposal through programmes such as the Electronic Prescription Service and access to the Summary Care Record, which is now accessible in over 95% of pharmacies.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/07/2018 15:02:54 answering member 4067 label Biography information for Steve Brine
	tabling member	4124 label Biography information for Chi Onwurah

934006

	registered interest
	date	02/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cervical Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what comparative assessment he has made of rates of cervical screening for 25-49 year olds in (a) Newcastle, (b) the North East and (c) the UK.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	159591
	answer	answer is ministerial correction date of answer 05/07/2018 answer text <p>The most recent quarterly data on coverage for women aged 25-49 years is from September 2017. It is reported that NHS Newcastle Gateshead Clinical Commissioning Group (CCG) obtained coverage of 67.63% whilst the North of England (combination of 64 CCGs) reported a 71.34% coverage rate. England (total for 2017 CCGs) reported a 69.1% coverage rate. This data is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/cervical-screening-coverage-and-data" target="_blank">https://www.gov.uk/government/publications/cervical-screening-coverage-and-data</a></p><p> </p><p>Public Health England has worked in collaboration with NHS Digital and Jo’s Cervical Cancer Trust to produce a data coverage interactive tool, available to view at the following link:</p><p> </p><p><a href="https://app.powerbi.com/view?r=eyJrIjoiMzU0OTVlOWUtNjM3ZS00OGIzLWJiNTctYmZjZGNlMjAyNmU5IiwidCI6IjgwN2YyZjMwLWNhOGMtNDE5Zi1hMTc5LTVjNGZjN2E0YmY2YiIsImMiOjN9" target="_blank">https://app.powerbi.com/view?r=eyJrIjoiMzU0OTVlOWUtNjM3ZS00OGIzLWJiNTctYmZjZGNlMjAyNmU5IiwidCI6IjgwN2YyZjMwLWNhOGMtNDE5Zi1hMTc5LTVjNGZjN2E0YmY2YiIsImMiOjN9</a></p><p> </p><p>The interactive tool provides timely at a glance data at local authority, CCG and general practice level. CCG and practice ranking is available with coverage maps. The data is updated quarterly and provides opportunity to evaluate local coverage initiatives in a timely way.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/07/2018 14:10:11 answering member 4067 label Biography information for Steve Brine
	tabling member	4124 label Biography information for Chi Onwurah

931196

	registered interest
	date	25/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cervical Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his policies on tackling inequalities in access to cervical screening of the report by Jo’s Cervical Cancer Trust entitled Computer says no, published in June 2018.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	157152
	answer	answer is ministerial correction date of answer 28/06/2018 answer text <p>All women should have timely and convenient access to cervical screening. Sexual and reproductive health (SRH) services traditionally offer and undertake both routine and opportunistic cervical cancer screening. These services accommodate a high risk cohort of women, which include those who are unlikely to access the screening programme via their general practitioner (GP), and women who are not registered with a GP.</p><p> </p><p>In tackling inequalities in access to cervical screening within SRH, NHS England local teams have worked with local authorities and sexual health providers to negotiate the continuation of opportunistic cervical screening over the last five years, and have committed to review the commissioning of this before the end of summer. NHS England will work with Public Health England and an expert group of stakeholders to explore what more can be done in terms of providing national guidance and case studies, and the development of an inequalities toolkit for screening to maximise uptake of screening amongst vulnerable groups.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 28/06/2018 11:30:48 answering member 4067 label Biography information for Steve Brine
	tabling member	4124 label Biography information for Chi Onwurah

923538

	registered interest
	date	13/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Drugs and Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of NHS England’s performance against its delivery of the 2016-17 mandate objective to implement the agreed recommendations of the Accelerated Access Review.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	153266
	answer	answer is ministerial correction date of answer 18/06/2018 answer text <p>The Department regularly reviews NHS England’s performance against the objectives, deliverables and requirements in the Government’s mandate to NHS England. The result of this assessment is set out in the Department’s annual assessment.</p><p> </p><p>NHS England is an active partner in the newly established Accelerated Access Collaborative, which will identify and support the most exciting innovations and we are working closely with NHS England to implement key recommendations from the Review, including delivering the Test Beds programme and expanding the role of the Academic Health Science Networks.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/06/2018 16:38:28 answering member 4067 label Biography information for Steve Brine
	tabling member	4124 label Biography information for Chi Onwurah

923541

	registered interest
	date	13/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Life Sciences Industrial Stategy, what steps his Department is taking to ensure the UK enters the top quartile of comparator countries for the speed of (a) adoption and (b) uptake of innovative, cost-effective medicines by 2023.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	153267
	answer	answer is ministerial correction date of answer 18/06/2018 answer text <p>The Life Sciences Industrial Strategy (LSIS) set out a vision of being a world-leader in developing and bringing to market innovative medicines to improve patient outcomes. The strategy, developed by the sector, included a strategic ambition for the UK to be in the top quartile of comparator countries for speed of adoption. The Government welcomes the ambition of the LSIS, and partners across the system are committed to maximising the appropriate use of innovative medicines to deliver better patient outcomes and support the long-term sustainability of the National Health Service.</p><p> </p><p>In December 2017, the Government published the Life Sciences Sector Deal, which detailed our commitments to taking forward the ambition in the LSIS. This included implementing the response to the Accelerated Access Review, which sets out a plan to increase the rate of uptake of innovative products. Progress to date includes establishing the Accelerated Access Collaborative which brings partners across the system together with the shared ambition of improving access to innovation in the NHS; developing the new Accelerated Access Pathway which will identify breakthrough treatments and get them to patients faster, and delivering £86 million funding to improve access to innovation, including by increasing the capacity and strengthening the mandate for the Academic Health and Science Networks.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 18/06/2018 15:31:57 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4124 label Biography information for Chi Onwurah

923542

	registered interest
	date	13/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Life Sciences Industrial Strategy, whether the next Annual Assessment Report of NHS performance will contain a detailed description of the (a) catalysts and (b) barriers to the UK entering the top quartile of comparator countries for the speed of (i) adoption and (ii) uptake of innovative, cost-effective medicines by 2023.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	153268
	answer	answer is ministerial correction date of answer 18/06/2018 answer text <p>The Department regularly reviews performance against the objectives, deliverables and requirements in the Government’s mandate to NHS England. The result of this assessment is set out in the Department’s annual assessment.</p><p> </p><p>The upper quartile strategic goal in the Life Science Industrial Strategy is not government policy and will therefore not be part of the Annual Assessment process. However, partners across the system are committed to maximising the appropriate use of innovative medicines to deliver better patient outcomes and support the long-term sustainability of the National Health Service. The Government continues to support and improve the Innovation Scorecard which tracks the uptake of innovative products approved by the National Institute for Health and Care Excellence.  It is designed to help users (clinicians, patients, commissioning groups, Government and other stakeholders) to understand and monitor the uptake of innovations in the NHS, and to use this information to continue to improve performance. We are continuing to increase the number of products covered by the scorecard, as well as to widen the range of medical technologies covered, including innovative diagnostic and digital products.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/06/2018 16:39:11 answering member 4067 label Biography information for Steve Brine
	tabling member	4124 label Biography information for Chi Onwurah

923551

	registered interest
	date	13/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Food: Advertising
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the health implications for deprived households of the advertising of food replacement systems including Huel as cheaper than food.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	153269
	answer	answer is ministerial correction date of answer 18/06/2018 answer text <p>The Government has no plans to make an assessment of commercial food replacement systems, such as Huel.</p><p> </p><p>Public Health England encourages everyone to have a healthy balanced diet in line with the nation’s healthy eating model the Eatwell Guide, available to view at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/the-eatwell-guide" target="_blank">https://www.gov.uk/government/publications/the-eatwell-guide</a></p><p> </p><p>This is promoted through a variety of communications including the Government’s 5 A DAY campaign, the Eatwell Guide, Public Health England’s catering guidance, through the Change4Life campaign and the NHS Choices website.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/06/2018 16:40:00 answering member 4067 label Biography information for Steve Brine
	tabling member	4124 label Biography information for Chi Onwurah

923552

	registered interest
	date	13/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 15 May 2018 to Question 142841 on Dental Health, what estimate he has made of the incidence of gum disease in each region of England.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	153270
	answer	answer is ministerial correction date of answer 18/06/2018 answer text <p>Levels of gum disease among adults are reported in the 2009 adult dental health survey. The prevalence by region is shown in the following table.</p><p> </p><table><tbody><tr><td><p>2008 Health Region</p></td><td><p>% with any bleeding of gums on probing</p></td><td><p>% with periodontal pockets measuring 4mm or deeper</p></td></tr><tr><td><p>North East</p></td><td><p>61</p></td><td><p>43</p></td></tr><tr><td><p>North West</p></td><td><p>51</p></td><td><p>43</p></td></tr><tr><td><p>Yorkshire and the Humber</p></td><td><p>62</p></td><td><p>42</p></td></tr><tr><td><p>East Midlands</p></td><td><p>60</p></td><td><p>44</p></td></tr><tr><td><p>West Midlands</p></td><td><p>61</p></td><td><p>53</p></td></tr><tr><td><p>East of England</p></td><td><p>32</p></td><td><p>32</p></td></tr><tr><td><p>London</p></td><td><p>49</p></td><td><p>46</p></td></tr><tr><td><p>South East Coast</p></td><td><p>52</p></td><td><p>49</p></td></tr><tr><td><p>South Central</p></td><td><p>64</p></td><td><p>39</p></td></tr><tr><td><p>South West</p></td><td><p>57</p></td><td><p>59</p></td></tr><tr><td><p>England</p></td><td><p>54</p></td><td><p>45</p></td></tr></tbody></table><p>Notes:</p><ol><li>This survey was undertaken in 2008 just before the National Health Service boundaries changed</li><li>Source: 2009 Adult Dental Health Survey:</li></ol><p> </p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/adult-dental-health-survey/adult-dental-health-survey-2009-summary-report-and-thematic-series" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/adult-dental-health-survey/adult-dental-health-survey-2009-summary-report-and-thematic-series</a></p><p> </p><p>Levels of gum inflammation among children in England were reported in the 2013 child dental health survey, but this is not available by region. The prevalence is shown in the following table.</p><p><strong> </strong></p><table><tbody><tr><td><p>Age group (year olds)</p></td><td><p>% of children with gum inflammation</p></td></tr><tr><td><p>5</p></td><td><p>22</p></td></tr><tr><td><p>8</p></td><td><p>46</p></td></tr><tr><td><p>12</p></td><td><p>61</p></td></tr><tr><td><p>15</p></td><td><p>53</p></td></tr></tbody></table><p> </p><p>Source: Child Dental Health Survey 2013:</p><p> </p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/children-s-dental-health-survey/child-dental-health-survey-2013-england-wales-and-northern-ireland" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/children-s-dental-health-survey/child-dental-health-survey-2013-england-wales-and-northern-ireland</a></p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Winchester answering member printed Steve Brine question first answered 18/06/2018 16:37:06 answering member 4067 label Biography information for Steve Brine
	tabling member	4124 label Biography information for Chi Onwurah

901371

	registered interest
	date	10/05/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the regional distribution of dental gum disease specialists is.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	142841
	answer	answer is ministerial correction date of answer 15/05/2018 answer text <p>This information is not held centrally.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/05/2018 16:24:55 answering member 4067 label Biography information for Steve Brine
	tabling member	4124 label Biography information for Chi Onwurah

862047

	registered interest
	date	14/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS Trusts: Hygiene
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, for what reasons the deadline of the end of 2017 for Public Health England to publish data on hand gel usage in NHS trusts has not been met.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	132466
	answer	answer is ministerial correction date of answer 19/03/2018 answer text <p>We recognise the importance of this ambition. Public Health England (PHE) has carried out some initial analysis with available data, however, currently the data is incomplete and would not give a true reflection of usage of hand gel.</p><p>The Department is continuing to work with PHE and NHS Improvement to determine methods to obtain hand gel data and produce a hand hygiene indicator underlying the critical link between hygiene and infection prevention.</p><p>Preventing infections is a priority for the Secretary of State and the Department published a revised code of practice setting good practice on hand hygiene compliance and strengthened the Infection Prevention and Control and antimicrobial stewardship framework for healthcare providers. The Department is also working with our partners across the health and social care system, including the Care Quality Commission, to ensure that consideration of best practice in hand hygiene policies remains a focus of inspections in acute trusts.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 19/03/2018 17:54:39 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4124 label Biography information for Chi Onwurah